Homebuyers are proving to have some pretty thick skin.
Home prices are still rising, supply is getting leaner, mortgage rates are going up and competition is intense.
Yet despite all the headwinds, buyers seem to be largely resolute.
“Buyer demand is still there and strong,” said Nela Richardson, chief economist at Redfin. “The only thing slowing demand is the lack of things to buy.”
Homes sold 7% faster in March compared to a year ago, according to realtor.com, while prices were 8% higher. At the same time, housing supply was down 8%.
And it doesn’t look like the search will be getting easier anytime soon.
“Very strong home prices are due to a real lack of supply … and prices are likely to continue to run well above inflation and income growth all over the country,” said Leonard Kiefer, deputy chief economist at Freddie Mac.
Best Growth Stocks To Watch For 2019: MEDIFAST INC(MED)
- [By Max Byerly]
MediBloc (CURRENCY:MED) traded 0.2% lower against the U.S. dollar during the twenty-four hour period ending at 16:00 PM Eastern on June 7th. MediBloc has a total market cap of $37.92 million and $586,074.00 worth of MediBloc was traded on exchanges in the last 24 hours. Over the last week, MediBloc has traded down 36% against the U.S. dollar. One MediBloc token can now be purchased for $0.0128 or 0.00000166 BTC on major exchanges including Coinrail, Bibox and Gate.io.
- [By Lisa Levin]
Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.
- [By Ethan Ryder]
MediBloc (CURRENCY:MED) traded 3.9% lower against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on June 13th. One MediBloc token can now be purchased for $0.0083 or 0.00000131 BTC on major cryptocurrency exchanges including Coinrail, Gate.io and Bibox. During the last seven days, MediBloc has traded 36.5% lower against the U.S. dollar. MediBloc has a total market cap of $24.58 million and $216,935.00 worth of MediBloc was traded on exchanges in the last day.
Best Growth Stocks To Watch For 2019: Nordstrom Inc.(JWN)
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Nordstrom (JWN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By ]
Cramer and the AAP team are sharing a positive research note on Norstrom (JWN) , and their analysis. Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
- [By JJ Kinahan]
Retail earnings take center stage the remainder of the week, but aside from that it’s a little hard right now to determine what sort of catalyst is out there that could give the market back some of the “giddy-up” it had last week. Unless the retail earnings really surpass expectations in a big way, it might be difficult to figure out what the next instigator to the upside might be. Thursday looks like a big day, with Walmart Inc. (NYSE: WMT) and J C Penney Company Inc. (NYSE: JCP) scheduled to report before the open and Nordstrom, Inc. (NYSE: JWN) after the close. One question moving into these reports is whether the recent strong retail sales data might have helped the retail sector beyond M.
- [By Stephan Byrd]
Nordstrom (NYSE:JWN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Nordstrom outperformed the industry in the last six months driven by the smooth execution of customer strategy and disciplined inventory management. The company has an impressive surprise history with earnings beat delivered in seven of the last eight quarters and topping sales estimates in three of the trailing four quarters. Results in first-quarter fiscal 2018 gained from the shift in Nordstrom’s loyalty event to the quarter compared with the second quarter in the prior year. Management raised the low-end of its EBIT and earnings views for fiscal 2018. Also, its focus on store expansion and strengthening capabilities through further investments, particularly in digital growth, remains noteworthy. However, investments toward occupancy, technology, supply chain and marketing are weighing on its margin performance for the last few quarters. Higher expenses have been resulting in higher SG&A expense, which is hurting profitability.”
Best Growth Stocks To Watch For 2019: Buffalo Wild Wings Inc.(BWLD)
- [By Steve Symington]
That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.
- [By Peter Graham]
A long term performance chart shows Dave & Busters Entertainmenttripling in valuebefore falling back whilesmall cap upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small capBuffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arbys Restaurant Group:
Best Growth Stocks To Watch For 2019: TrueBlue Inc.(TBI)
- [By Stephan Byrd]
Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.
- [By Stephan Byrd]
American Century Companies Inc. grew its holdings in shares of Trueblue Inc (NYSE:TBI) by 24.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 95,307 shares of the business services provider’s stock after purchasing an additional 18,680 shares during the period. American Century Companies Inc. owned approximately 0.23% of Trueblue worth $2,468,000 as of its most recent SEC filing.
- [By Joseph Griffin]
Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.